GLAXO
GLAXOSMITHKLINE PHARMA LTHealthcare
LTP
2,599.7
CHG · %
+20.2 (+0.78%)
VOL · TODAY
34.99K
PREV CLOSE
2,579.5
Today's range2,556.5 · 2,624.9
2,599.7
52-week range2,088.1 · 2,895
2,599.7
Loading candles…
GlaxoSmithKline Pharmaceuticals Limited is an Indian biopharmaceutical company operating as a subsidiary of GSK plc. The company researches, manufactures, and distributes a broad range of medicines and vaccines within India. Its operations include local manufacturing of general medicines and importing advanced vaccines and specialty treatments. GlaxoSmithKline Pharmaceuticals Limited serves multiple segments including private vaccines, dermatology, anti-infectives, pain management, respiratory, and specialty medicines. The company has maintained a presence in India for over a century and holds a significant market position in the private vaccines and dermatology segments. It also participates in initiatives such as the "Make in India" program. The company operates primarily within the pharmaceutical, healthcare, and biopharmaceutical industries.
This page is a live market overview for GLAXOSMITHKLINE PHARMA LT (GLAXO) on the NSE. As a listed security, GLAXOSMITHKLINE PHARMA LT is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for GLAXO before placing trades on tick2trade.
As of the latest feed, GLAXO last traded at ₹2,599.7 on NSE, up ₹20.2 (0.78%) from the previous close of ₹2,579.5. Today's session range is ₹2,556.5 – ₹2,624.9, against a 52-week band of ₹2,088.1 – ₹2,895. Traded volume today stands at 34.99K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for GLAXO in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether GLAXO is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for GLAXOSMITHKLINE PHARMA LT before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in GLAXO. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated GLAXO option chain page linked from this overview.
// similar in healthcare314 total